Monday, February 6, 2023


JelikaLite Announces Positive Results From a New Feasibility Study, Successful Raise of $760,000 and Acceptance into Mount Sinai Elementa Labs Program

Pilot study data suggests that JelikaLite’s Cognilum medical device reduces symptoms of autism in young children and improves the quality of life of their families.

Dymicron Launches Regulation A+ Equity Crowdfunding Investment Offering

Dymicron has partnered with DealMaker for its self-hosted $15.8 million raise. Regulation A+ raise. Regulation A+ is a relatively new exemption which allows private companies to sell their shares to unaccredited investors.

Miach Orthopaedics Secures $40 Million Financing

Miach Orthopaedics advises funds will enable ongoing operations and expand the U.S. commercial rollout of the BEAR Implant.

Ferronova Secures A$11 Million to Advance Nanotech Image-guided Cancer Therapy

Ferronova CEO Stewart Bartlett said raising capital in a challenging environment and winning a CRC-P grant was a credit to the strength of Ferronova's technology.

Visura Announces Closing of Series B Financing

Funding will support the company's rapid, full commercialization of its TEECAD® System. "These significant investments underscore the tremendous confidence in our state-of-the-art solution, experienced team, and the growth trajectory we are on to fully commercialize our TEECAD System," says Christine Horton, president and CEO of Visura.

Cardiac Dimensions Raises $35M in Series D Round

Cardiac Dimensions reports financing was co-led by existing investor Horizon 3 Healthcare and an undisclosed strategic investor, with all other existing investors participating, including Arboretum Ventures, Hostplus, EQT Life Sciences (formerly LSP), Lumira Ventures, and M. H. Carnegie & Co.

By using this website you agree to accept Medical Device News Magazine Privacy Policy